As of 2025-09-17, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (59.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -133.5%.
The range of the Relative Valuation is (59.85) - (62.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.1x | 14.5x |
| Forward P/E multiples | 13.8x - 14.7x | 13.9x |
| Fair Price | (59.85) - (62.22) | (59.94) |
| Upside | -133.5% - -134.8% | -133.5% |
| Date | P/E |